Pearlify UI

Pearlify Data Viewer

read-only

홈 · 표

재무제표 주요계정

보고서별 핵심 계정(매출·이익·자산 등). 계정명은 공시 원문 그대로, 지표는 규칙으로 매핑합니다.

기술 정보 숨기기
ID수집원원본 키발생값 ↓시간 정밀도시간 의미관측 가능 시각적재일시원본 레코드파서 버전원시 식별자법인DART 코드회사명사업연도기간연결구분재무제표계정명표준 지표금액통화기준일접수번호
cmrxew1a201u30zgw8xpeazfldart-financials00877059:2025:11013:CFS:BS:자본금2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSBS자본금capital_stock1779.3억원KRW2025-03-3120250515002264
cmrxew1aa01u40zgwyi3b2tqwdart-financials00877059:2025:11013:CFS:BS:이익잉여금2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSBS이익잉여금retained_earnings5.4조원KRW2025-03-3120250515002264
cmrxew1ag01u50zgwe1pudnljdart-financials00877059:2025:11013:CFS:BS:자본총계2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSBS자본총계total_equity11.2조원KRW2025-03-3120250515002264
cmrxew1an01u60zgwgnboco9vdart-financials00877059:2025:11013:CFS:IS:매출액2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSIS매출액revenue1.2조원KRW2025-03-3120250515002264
cmrxew1at01u70zgwwkv6vritdart-financials00877059:2025:11013:CFS:IS:영업이익2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSIS영업이익operating_income4866.8억원KRW2025-03-3120250515002264
cmrxew1b001u80zgwhadjmzxsdart-financials00877059:2025:11013:CFS:IS:법인세차감전 순이익2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSIS법인세차감전 순이익pretax_income4993.8억원KRW2025-03-3120250515002264
cmrxew1b601u90zgwrqsw6nj2dart-financials00877059:2025:11013:CFS:IS:당기순이익(손실)2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSIS당기순이익(손실)net_income3755.5억원KRW2025-03-3120250515002264
cmrxew1bd01ua0zgwsdrkhs0udart-financials00877059:2025:11013:CFS:IS:총포괄손익2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1CFSIS총포괄손익comprehensive_income3754.3억원KRW2025-03-3120250515002264
cmrxew1bk01ub0zgwqh0edt20dart-financials00877059:2025:11013:OFS:BS:유동자산2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS유동자산current_assets3.6조원KRW2025-03-3120250515002264
cmrxew1bq01uc0zgwo7zyp39gdart-financials00877059:2025:11013:OFS:BS:비유동자산2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS비유동자산non_current_assets9.7조원KRW2025-03-3120250515002264
cmrxew1bx01ud0zgw125ro469dart-financials00877059:2025:11013:OFS:BS:자산총계2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS자산총계total_assets13.3조원KRW2025-03-3120250515002264
cmrxew1c401ue0zgwve6viy5zdart-financials00877059:2025:11013:OFS:BS:유동부채2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS유동부채current_liabilities2.4조원KRW2025-03-3120250515002264
cmrxew1ca01uf0zgwad8b1mm1dart-financials00877059:2025:11013:OFS:BS:비유동부채2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS비유동부채non_current_liabilities1.3조원KRW2025-03-3120250515002264
cmrxew1ch01ug0zgwujx9lx2bdart-financials00877059:2025:11013:OFS:BS:부채총계2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS부채총계total_liabilities3.7조원KRW2025-03-3120250515002264
cmrxew1cn01uh0zgw1vppe12edart-financials00877059:2025:11013:OFS:BS:자본금2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS자본금capital_stock1779.3억원KRW2025-03-3120250515002264
cmrxew1cu01ui0zgw9zzy9sszdart-financials00877059:2025:11013:OFS:BS:이익잉여금2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS이익잉여금retained_earnings3.7조원KRW2025-03-3120250515002264
cmrxevxpx01900zgw88k8z8dxdart-financials00413046:2025:11013:OFS:IS:총포괄손익2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSIS총포괄손익comprehensive_income1662.5억원KRW2025-03-3120250515002745
cmrxevxpr018z0zgw65fum6kndart-financials00413046:2025:11013:OFS:IS:당기순이익(손실)2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSIS당기순이익(손실)net_income1665.7억원KRW2025-03-3120250515002745
cmrxevxpl018y0zgw7qgb8t7zdart-financials00413046:2025:11013:OFS:IS:법인세차감전 순이익2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSIS법인세차감전 순이익pretax_income2030.2억원KRW2025-03-3120250515002745
cmrxevxpf018x0zgwa7u7s279dart-financials00413046:2025:11013:OFS:IS:영업이익2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSIS영업이익operating_income1364.2억원KRW2025-03-3120250515002745
cmrxevxp9018w0zgwij3pzb29dart-financials00413046:2025:11013:OFS:IS:매출액2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSIS매출액revenue6340억원KRW2025-03-3120250515002745
cmrxevxp4018v0zgwt7vaav4bdart-financials00413046:2025:11013:OFS:BS:자본총계2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS자본총계total_equity17.3조원KRW2025-03-3120250515002745
cmrxevxox018u0zgw1nq0i8izdart-financials00413046:2025:11013:OFS:BS:이익잉여금2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS이익잉여금retained_earnings4.3조원KRW2025-03-3120250515002745
cmrxevxor018t0zgwa84srqm1dart-financials00413046:2025:11013:OFS:BS:자본금2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS자본금capital_stock2308억원KRW2025-03-3120250515002745
cmrxevxol018s0zgwoaq1so0qdart-financials00413046:2025:11013:OFS:BS:부채총계2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS부채총계total_liabilities2.7조원KRW2025-03-3120250515002745
cmrxevxof018r0zgwenyv2ay4dart-financials00413046:2025:11013:OFS:BS:비유동부채2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS비유동부채non_current_liabilities1399.5억원KRW2025-03-3120250515002745
cmrxevxo9018q0zgwnee3jva7dart-financials00413046:2025:11013:OFS:BS:유동부채2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS유동부채current_liabilities2.6조원KRW2025-03-3120250515002745
cmrxevxo3018p0zgwxvikdt2ndart-financials00413046:2025:11013:OFS:BS:자산총계2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS자산총계total_assets20조원KRW2025-03-3120250515002745
cmrxevxnx018o0zgw3z2c5v1adart-financials00413046:2025:11013:OFS:BS:비유동자산2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS비유동자산non_current_assets14.9조원KRW2025-03-3120250515002745
cmrxevxns018n0zgwkdezp1fhdart-financials00413046:2025:11013:OFS:BS:유동자산2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1OFSBS유동자산current_assets5.1조원KRW2025-03-3120250515002745
cmrxevxnl018m0zgwykb0i2t9dart-financials00413046:2025:11013:CFS:IS:총포괄손익2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSIS총포괄손익comprehensive_income1086.2억원KRW2025-03-3120250515002745
cmrxevxne018l0zgwphhh5rhadart-financials00413046:2025:11013:CFS:IS:당기순이익(손실)2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSIS당기순이익(손실)net_income1083.3억원KRW2025-03-3120250515002745
cmrxevxn8018k0zgwtby8ph7odart-financials00413046:2025:11013:CFS:IS:법인세차감전 순이익2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSIS법인세차감전 순이익pretax_income1954.8억원KRW2025-03-3120250515002745
cmrxevxn2018j0zgwuh7xhbxxdart-financials00413046:2025:11013:CFS:IS:영업이익2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSIS영업이익operating_income1494.2억원KRW2025-03-3120250515002745
cmrxevxmw018i0zgwsmwzg0nvdart-financials00413046:2025:11013:CFS:IS:매출액2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSIS매출액revenue8419.1억원KRW2025-03-3120250515002745
cmrxevxmq018h0zgwvigwksbudart-financials00413046:2025:11013:CFS:BS:자본총계2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS자본총계total_equity17.2조원KRW2025-03-3120250515002745
cmrxevxmk018g0zgwfl3f4mhrdart-financials00413046:2025:11013:CFS:BS:이익잉여금2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS이익잉여금retained_earnings3.6조원KRW2025-03-3120250515002745
cmrxevxme018f0zgwi6pb5mm1dart-financials00413046:2025:11013:CFS:BS:자본금2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS자본금capital_stock2308억원KRW2025-03-3120250515002745
cmrxevxm8018e0zgwhan575fgdart-financials00413046:2025:11013:CFS:BS:부채총계2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS부채총계total_liabilities3.6조원KRW2025-03-3120250515002745
cmrxevxm3018d0zgwev6qogd3dart-financials00413046:2025:11013:CFS:BS:비유동부채2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS비유동부채non_current_liabilities2747.7억원KRW2025-03-3120250515002745
cmrxevxlw018c0zgw683gmml1dart-financials00413046:2025:11013:CFS:BS:유동부채2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS유동부채current_liabilities3.4조원KRW2025-03-3120250515002745
cmrxevxlq018b0zgwsj4wdssidart-financials00413046:2025:11013:CFS:BS:자산총계2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS자산총계total_assets20.9조원KRW2025-03-3120250515002745
cmrxevxlk018a0zgwc0givln2dart-financials00413046:2025:11013:CFS:BS:비유동자산2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS비유동자산non_current_assets15.4조원KRW2025-03-3120250515002745
cmrxevxle01890zgwskkhwokhdart-financials00413046:2025:11013:CFS:BS:유동자산2025-05-15dayevent2026-07-23 20:12:012026-07-23 20:12:01cmrxevxl601880zgw5rjtmmtq1
{ "value": "00413046", "scheme": "corp_code" }
{
  "value": "00413046",
  "scheme": "corp_code"
}
—00413046셀트리온2,025Q1CFSBS유동자산current_assets5.4조원KRW2025-03-3120250515002745
cmrxew1d001uj0zgwipq8r521dart-financials00877059:2025:11013:OFS:BS:자본총계2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSBS자본총계total_equity9.5조원KRW2025-03-3120250515002264
cmrxew1d701uk0zgw5aj2mgqqdart-financials00877059:2025:11013:OFS:IS:매출액2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSIS매출액revenue9995.4억원KRW2025-03-3120250515002264
cmrxew1dg01ul0zgw5x1qaftldart-financials00877059:2025:11013:OFS:IS:영업이익2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSIS영업이익operating_income4300.1억원KRW2025-03-3120250515002264
cmrxew1dm01um0zgwv2kle9fadart-financials00877059:2025:11013:OFS:IS:법인세차감전 순이익2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSIS법인세차감전 순이익pretax_income4232.3억원KRW2025-03-3120250515002264
cmrxew1dt01un0zgwwwytaziudart-financials00877059:2025:11013:OFS:IS:당기순이익(손실)2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSIS당기순이익(손실)net_income3195.7억원KRW2025-03-3120250515002264
cmrxew1dz01uo0zgwrwzdcsoudart-financials00877059:2025:11013:OFS:IS:총포괄손익2025-05-15dayevent2026-07-23 20:12:062026-07-23 20:12:06cmrxew18s01tw0zgw7gxvme7a1
{ "value": "00877059", "scheme": "corp_code" }
{
  "value": "00877059",
  "scheme": "corp_code"
}
—00877059삼성바이오로직스2,025Q1OFSIS총포괄손익comprehensive_income3190.4억원KRW2025-03-3120250515002264
4,008건 중 3,501–3,550← 이전71 / 81 쪽다음 →

fundamental_facts · 컬럼 24개 · occurredAt desc 정렬